Pasadena Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Hold
3,319
0.15% 81
2026
Q1
$1.17M Hold
3,319
0.16% 78
2025
Q4
$1.09M Hold
3,319
0.15% 77
2025
Q3
$937K Hold
3,319
0.13% 71
2025
Q2
$927K Hold
3,319
0.16% 66
2025
Q1
$1.03M Hold
3,319
0.2% 61
2024
Q4
$865K Hold
3,319
0.18% 67
2024
Q3
$1.07M Buy
3,319
+1,410
+74% +$461K 0.23% 50
2024
Q2
$596K Sell
1,909
-951
-33% -$279K 0.14% 73
2024
Q1
$813K Buy
2,860
+635
+29% +$186K 0.19% 56
2023
Q4
$641K Hold
2,225
0.16% 68
2023
Q3
$598K Sell
2,225
-400
-15% -$99.8K 0.18% 45
2023
Q2
$583K Buy
+2,625
New +$609K 0.16% 47

Other funds holding AMGN

Pasadena Private Wealth's AMGN Position: Q2 2026 in Review

Pasadena Private Wealth held its Amgen (AMGN) position steady in Q2 2026 at 3,319 shares worth $1.2M. The position accounts for 0.15% of the portfolio, ranked #81.

Pasadena Private Wealth first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. 3,146 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Pasadena Private Wealth held 3,319 shares of Amgen worth $1.2M as of Q2 2026.
  • Pasadena Private Wealth left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.15% of Pasadena Private Wealth's portfolio in Q2 2026, its #81 holding.
  • Pasadena Private Wealth first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Pasadena Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.